ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 176 filers reported holding ASCENDIS PHARMA A/S in Q4 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $674,208 | +18.0% | 7,200 | +12.5% | 0.04% | +18.9% |
| Q2 2023 | $571,200 | -33.4% | 6,400 | -20.0% | 0.04% | -27.5% |
| Q1 2023 | $857,760 | -3.8% | 8,000 | +9.6% | 0.05% | +10.9% |
| Q4 2022 | $891,549 | +72.8% | 7,300 | +46.0% | 0.05% | +142.1% |
| Q3 2022 | $516,000 | +11.0% | 5,000 | -0.0% | 0.02% | +46.2% |
| Q2 2022 | $465,000 | +72.2% | 5,001 | +117.4% | 0.01% | +62.5% |
| Q1 2022 | $270,000 | -59.9% | 2,300 | -54.0% | 0.01% | -52.9% |
| Q4 2021 | $673,000 | +111.0% | 5,000 | +149.5% | 0.02% | +112.5% |
| Q3 2021 | $319,000 | +21.3% | 2,004 | +0.2% | 0.01% | 0.0% |
| Q2 2021 | $263,000 | -48.9% | 2,000 | -40.1% | 0.01% | -68.0% |
| Q3 2020 | $515,000 | – | 3,340 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |